close
MENU
4 mins to read

Supplier problems cost AFT Pharmaceuticals $A2m

Pharmaceuticals company is aiming for 60% of its revenue to be generated outside of Australia and New Zealand in five years' time. With special feature audio.

Campbell Gibson
Wed, 25 May 2016

AFT Pharmaceuticals [NZX: AFT] says it lost approximately $A2 million in revenue due to low production levels from a significant supplier.

In its maiden full-year results since listing, the Auckland-based drug development company announced total revenue rose 14% to $64 million and an operating

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Campbell Gibson
Wed, 25 May 2016
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Supplier problems cost AFT Pharmaceuticals $A2m
58485
true